Skip to main content
. Author manuscript; available in PMC: 2021 Jul 14.
Published in final edited form as: Gynecol Oncol. 2020 Feb 21;157(2):508–513. doi: 10.1016/j.ygyno.2020.02.029

Table 2.

Characteristics stratified by hospital volume quartiles

Characteristics Low Medium Low Medium High High P-value
N % N % N % N %
Number of patients 1,058 (30.5) 519 (15.0) 1,012 (29.2) 880 (25.4)
Number of hospitals
Age of diagnosis 0.47
 <40 323 (30.5) 174 (33.5) 342 (33.8) 303 (34.4)
 40–49 349 (33.0) 153 (29.5) 311 (30.7) 296 (33.6)
 50–59 214 (20.2) 106 (20.4) 209 (20.7) 164 (18.6)
 60–69 199 (11.2) 66 (12.7) 111 (11.0) 76 (8.6)
 70–79 41 (3.9) 15 (2.9) 29 (2.9) 33 (3.8)
 >/=80 12 (1.1) * * 10 (1.0) * *
Race 0.01
 White 723 (68.3) 351 (67.6) 642 (63.4) 602 (68.4)
 Black 112 (10.6) 59 (11.4) 113 (11.2) 100 (11.4)
 Hispanic 149 (14.1) 70 (13.5) 176 (17.4) 123 (14.0)
 Other 54 (5.1) 36 (6.9) 75 (7.4) 50 (5.7)
 Unknown 20 (1.9) * * * * * *
Year of diagnosis 0.001
 2011 353 (33.4) 182 (35.1) 332 (32.8) 293 (33.3)
 2012 366 (34.6) 186 (35.8) 295 (29.2) 320 (36.4)
 2013 339 (32.0) 151 (29.1) 385 (38.0) 267 (30.3)
Insurance 0.03
 Uninsured 59 (5.6) 36 (6.9) 86 (8.5) 86 (9.8)
 Private 611 (57.8) 303 (58.4) 566 (55.9) 509 (57.8)
 Medicaid 225 (21.3) 111 (21.4) 199 (19.7) 155 (17.6)
 Medicare 124 (11.7) 55 (10.6) 126 (12.5) 90 (10.2)
 Other government/unknown 39 (3.7) 14 (2.7) 35 (3.5) 40 (4.5)
Median household income 0.02
 <$38,000 176 (16.6) 88 (17.0) 220 (21.7) 177 (20.1)
 $38,000-$47,999 258 (24.4) 114 (22.0) 268 (26.5) 213 (24.2)
 $48,000-$62,999 308 (29.1) 150 (28.9) 245 (24.2) 243 (27.6)
 $63,000+ 315 (29.8) 164 (31.6) 278 (27.5) 244 (27.7)
 Unknown * * * * * * * *
Patient’s Residence Area <0.001
 Metropolitan 899 (85.0) 432 (83.2) 836 (82.6) 694 (78.9)
 Urban 121 (11.4) 61 (11.8) 135 (13.3) 141 (16.0)
 Rural 17 (1.6) 16 (3.1) 14 (1.4) * *
 Unknown 21 (2.0) 10 (1.9) 27 (2.7) 37 (4.2)
Comorbidity score 0.65
 0 910 (86.0) 445 (85.7) 891 (88.0) 766 (87.0)
 1 120 (11.3) 62 (11.9) 105 (10.4) 93 (10.6)
 >/= 2 28 (2.6) 12 (2.3) 16 (1.6) 21 (2.4)
Facility type <0.001
 Community cancer 78 (7.4) 17 (3.3) 14 (1.4) * *
 Comprehensive community Ca 488 (46.1) 192 (37.0) 341 (33.7) 193 (21.9)
 Academic/Research 356 (33.6) 211 (40.7) 513 (50.7) 626 (71.1)
 Integrated network cancer 136 (12.9) 99 (19.1) 144 (14.2) 61 (6.9)
Facility location <0.001
 Northeast 200 (18.9) 114 (22.0) 161 (15.9) 108 (12.3)
 Midwest 289 (27.3) 102 (19.7) 196 (19.4) 221 (25.1)
 South 356 (33.6) 183 (35.3) 440 (43.5) 396 (45.0)
 West 213 (20.1) 120 (23.1) 215 (21.2) 155 (17.6)
Stage <0.001
 1A2 190 (18.0) 78 (15.0) 102 (10.1) 106 (12.0)
 1B1 868 (82.0) 441 (85.0) 910 (89.9) 774 (88.0)
Histology 0.66
 Squamous cell 634 (59.9) 312 (60.1) 595 (58.8) 502 (57.0)
 Adenocarcinoma 376 (35.5) 176 (33.9) 360 (35.6) 325 (36.9)
 Adenosquamous 48 (4.5) 31 (6.0) 57 (5.6) 53 (6.0)
Grade 0.002
 Well 203 (19.2) 103 (19.8) 153 (15.1) 129 (14.7)
 Moderate 482 (45.6) 228 (43.9) 437 (43.2) 436 (49.5)
 Poorly 279 (26.4) 142 (27.4) 324 (32.0) 221 (25.1)
 Unknown 94 (8.9) 46 (8.9) 98 (9.7) 94 (10.7)
Hysterectomy type <0.001
 Simple 427 (40.4) 178 (34.3) 347 (34.3) 274 (31.1)
 Radical 631 (59.6) 341 (65.7) 665 (65.7) 606 (68.9)
Route of surgery 0.35
 Open 429 (40.5) 217 (41.8) 432 (42.7) 392 (44.5)
 Minimally invasive 629 (59.5) 302 (58.2) 580 (57.3) 488 (55.5)
Lymphadenectomy <0.001
 No 134 (12.7) 39 (7.5) 62 (6.1) 34 (3.9)
 Yes 924 (87.3) 480 (92.5) 950 (93.9) 846 (96.1)
*

Fewer than 10 patients